Impact of a new assay for measuring serum creatinine levels on carboplatin dosing
Author:
Affiliation:
1. University of North Carolina Hospitals and Clinics, Chapel Hill
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/69/13/1136/28455290/ajhp1136.pdf
Reference27 articles.
1. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin;Go;J Clin Oncol,1999
2. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors;Kondagunta;J Clin Oncol,2005
3. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide;Williams;N Engl J Med,1987
4. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide;Turrisi;N Engl J Med,1999
5. Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study;Hoskins;J Clin Oncol,2001
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmaceutical waste: a health risk for humans;360-Degree Waste Management, Volume 2;2023
2. CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer;Clinical Cancer Research;2020-12-10
3. Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP);Breast Cancer Research and Treatment;2020-08-29
4. Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care;Gynecologic Oncology;2020-06
5. Effects of Pioglitazone and Irbesartan on Endothelial Dysfunction on Experimentally Streptozotocin-Induced Diabetic Nephropathy in Rats;Egyptian Journal of Basic and Clinical Pharmacology;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3